- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05140642
Safety and Efficacy Study of AI LVEF (EchoNet-RCT)
June 30, 2022 updated by: David Ouyang, Cedars-Sinai Medical Center
Blinded Randomized Controlled Trial of Artificial Intelligence Guided Assessment of Cardiac Function
To determine whether an integrated AI decision support can save time and improve accuracy of assessment of echocardiograms, the investigators are conducting a blinded, randomized controlled study of AI guided measurements of left ventricular ejection fraction compared to sonographer measurements in preliminary readings of echocardiograms.
Study Overview
Status
Completed
Conditions
Study Type
Interventional
Enrollment (Actual)
3495
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Los Angeles, California, United States, 90048
- Cedars-Sinai Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 110 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- The study imaging studies will include patients who underwent imaging (limited or comprehensive transthoracic echocardiogram studies) and a LVEF was adjudicated in the echocardiography/non-invasive cardiac imaging laboratory.
- The study participants are cardiologists reading in the echocardiography/non-invasive cardiac imaging laboratory.
Exclusion Criteria:
- The study imaging studies will exclude transesophageal echocardiogram imaging.
- The study will exclude cardiologists who decline to participate
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Sonographer Annotation
Currently, sonographer technicians provide preliminary interpretations prior to validation and overreading by cardiologists.
This staggered, stepwise evaluation allows for the introduction of AI decision support with minimal impact on patient care.
Physicians are already used to adjusting the preliminary report given the variable training of sonographers and on the lookout for changes, variation, or adjustments that need to be made.
|
Standard practice sonographer measurement of left ventricle and assessment of LVEF
|
Experimental: Artificial Intelligence Annotation
In preliminary work, a novel AI algorithm developed to assess LVEF was shown to be more precise than human interpretation in 10,030 echocardiograms done at Stanford University (Ouyang et al.
Nature, 2020).
With randomization, a proportion of the preliminary interpretations will be done by AI technology and the study team will assess how different this preliminary interpretation is from the final interpretation.
|
A semantic segmentation deep learning model will identify the left ventricle and label the left ventricle.
The AI model will produce an assessment of LVEF using video based features.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Frequency of >5% change in LVEF between preliminary and final report
Time Frame: 10 Minutes
|
Proportion of studies the LVEF is changed more than 5% in final report
|
10 Minutes
|
Average change in LVEF between preliminary and final report
Time Frame: 10 Minutes
|
Mean change in LVEF between preliminary and final report
|
10 Minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Frequency cardiologist adjusts preliminary annotation
Time Frame: 10 Minutes
|
Proportion of studies the annotation is changed
|
10 Minutes
|
Average change in LVEF between prior clinical report and final report
Time Frame: 10 Minutes
|
Mean change in LVEF between prior clinical report and final report
|
10 Minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 1, 2022
Primary Completion (Actual)
June 29, 2022
Study Completion (Actual)
June 29, 2022
Study Registration Dates
First Submitted
November 17, 2021
First Submitted That Met QC Criteria
November 30, 2021
First Posted (Actual)
December 1, 2021
Study Record Updates
Last Update Posted (Actual)
July 5, 2022
Last Update Submitted That Met QC Criteria
June 30, 2022
Last Verified
June 1, 2022
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- STUDY00001707
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Heart Failure, Diastolic
-
Emory UniversityUnknownDiastolic Heart Failure | Diastolic DysfunctionUnited States
-
CorAssist Cadiovascular Ltd.RecruitingDiastolic Heart Failure | Diastolic DysfunctionIsrael
-
University of VermontCompletedDiastolic Heart Failure | Diastolic Dysfunction | PacemakerUnited States
-
University of NebraskaTerminatedDiastolic Heart FailureUnited States
-
Arizona State UniversityMayo Clinic; University of AlbertaCompleted
-
University of Wisconsin, MadisonTerminatedDiastolic Heart FailureUnited States
-
University of PennsylvaniaCompletedHeart Failure | Diastolic Heart FailureUnited States
-
Chang Gung Memorial HospitalCompleted
-
Duke UniversityNational Heart, Lung, and Blood Institute (NHLBI); PfizerCompleted
-
St Vincent's University Hospital, IrelandCompletedThe Effect of Eplerenone and Atorvastatin on Markers of Collagen Turnover in Diastolic Heart FailureDiastolic Heart FailureIreland
Clinical Trials on Sonographer Measurement of LVEF
-
Assistance Publique Hopitaux De MarseilleCompleted
-
Istanbul Medeniyet UniversityNot yet recruiting
-
Helios Health Institute GmbHHeart Center Leipzig - University HospitalRecruitingCoronary Artery Disease | Coronary Artery StenosesGermany
-
GULIN FINDIKOGLUCompletedDiabetes Mellitus, Type 2 | Gait Disorder, SensorimotorTurkey
-
Hasselt UniversityTRACE labs Ziekenhuis Oost-Limburg (ZOL)Recruiting
-
Marmara UniversityCompletedVenous Insufficiency | Foot Drop (Acquired)Turkey
-
University of MalayaRottapharmCompletedNon-alcoholic Fatty Liver DiseaseMalaysia
-
Centre Hospitalier Universitaire de NīmesRecruiting
-
Sotera Wireless, Inc.UnknownSleep Apnea, ObstructiveUnited States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)Terminated